Please assess the completion status of the following clinical trial:

Trial Title: A Trial of Evonail® Solution for Prevention or Treatment of Onycholysis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with breast cancer receiving adjuvant/neoadjuvant docetaxel chemotherapy~Exclusion Criteria:~* Patients with breast cancer receiving palliative docetaxel chemotherapy~* Patients having onycholysis before docetaxel treatment

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Experimental arm (Type: EXPERIMENTAL): In experimental arm, each patient painted EVONAIL® solution on nails and periungual areas once a day till developing onycholysis grade 2 or more.
- Control arm (Type: OTHER): In control arm, each patient painted EVONAIL® solution on nails and periungual area twice a day after developing onycholysis grade 2.~This study design allowed cross-over. Therefore, this control arm would give EVONAIL® solution after developing onlycholysis grade 2 in spite of control arm.

Based on this trial design, predict the completion outcome and termination type (if applicable).